Clinical trials of new drugs and treatments have a high failure rate. Better planning and technology-aided communication, says Dr. Harsha Rajasimha of Jeeva Trials, can
Disparities related to diversity, equity, and inclusion (DEI) are common and well-known in clinical trials. It is well-documented that racial minorities, underprivileged, and non-white ethnic
Evidence linking interventions with health outcomes is vital for healthcare decision-making. Making sound choices about healthcare requires the best possible and quality evidence from clinical
Even though the COVID-19 pandemic raised global awareness of clinical trials, most adults have never seen an advertisement recruiting volunteers to participate. In the U.S.,
Over the last two years, testing of new drugs, medical devices, and vaccines has increasingly been done outside large medical centers. To benefit both sponsors
Source: Pharmacy Times With the ongoing COVID-19 pandemic, the importance of rigorous clinical trials has been at the center of discussions regarding the development and
Source: Medium In recent years, Big Tech has gotten a bad rep. But of course many tech companies are doing important work making monumental positive
Patient test groups for new drugs and treatments, notes Dr. Harsha Rajasimha of Jeeva Trials, tend to be non-diverse. However, recently developed digital health technologies
By: Harsha K. Rajasimha, MS, PhD & Sharlene Brown, PhD Clinical trials are the regulatory mechanisms agencies like the Food and Drug Administration (FDA) use
By Harsha Rajasimha, Ph.D., Founder and CEO The precision medicine paradigm is all about targeting medicines to patient cohorts that are most likely to benefit from
Jeeva Clinical Trials Inc.
